瘤免疫逃避:来自CRISPR屏幕的见解和未来的方向
Tirta Mario Djajawi1,2, Johannes Wichmann3, Stephin J Vervoort3
1Olivia Newton-John Cancer Research Institute, Heidelberg, Vic., Australia.
The FEBS journal
|November 16, 2023
概括
癌症免疫疗法看起来很有前途,但许多患者没有反应. 了解瘤免疫逃避途径对于开发下一代疗法和改善患者治疗结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 癌症免疫疗法,如免疫检查点封锁和采用细胞疗法,已经取得了临床成功.
- 然而,大量患者因缺乏了解瘤免疫逃避机制而没有反应或复发.
- 需要系统层面的了解瘤免疫逃避,以设计更有效的免疫疗法.
研究的目的:
- 提供关于CRISPR查方法的观点,用于询问癌症中的瘤-淋巴细胞相互作用.
- 讨论当前CRISPR选方法在了解免疫逃避方面的局限性.
- 探索未来的技术发展,以加强对免疫逃避途径的发现.
主要方法:
- 克里斯普尔查方法是识别参与瘤免疫逃避的基因的强大工具.
- 这些大规模的基因选已经阐明了在癌症中颠覆的关键免疫逃避途径.
- 该研究回顾并讨论了这些查技术的应用和局限性.
主要成果:
- 克里斯普尔屏幕揭示了基本免疫学,并确定了癌症利用的关键免疫逃避途径.
- 这些发现推动了针对这些逃避过程的新型免疫疗法的开发.
- 尽管取得了成功,但当前的选方法有局限性,阻碍了对分子调节的全面理解.
结论:
- 克里斯普尔查显著提高了对瘤免疫逃避途径的理解.
- 进一步的技术开发是必要的,以克服局限性,并提高发现的分子调节器的免疫逃避.
- 加强查能力对于设计下一代癌症免疫疗法至关重要.
相关概念视频
01:27Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
02:53CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K